E

E. Robert McDonald

Novartis (Switzerland)

ORCID: 0000-0001-8165-9381

Publishes on CRISPR and Genetic Engineering, Protein Degradation and Inhibitors, Chromatin Remodeling and Cancer. 70 papers and 15.5k citations.

PubIndex Score94Top 6% · seniorHow it's scored

70Publications

15.5kTotal Citations

First publication: 1990First senior author: 2007

CRISPR and Genetic Engineering Protein Degradation and Inhibitors Chromatin Remodeling and Cancer Genomics and Chromatin Dynamics Cancer-related Molecular Pathways

Top publicationsby citations

Next-generation characterization of the Cancer Cell Line Encyclopedia

Mahmoud Ghandi, Marcin Imieliński, Craig M. Bielski et al.|Nature|2019

Cited by 3.7k

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao, Zongyao Wang, Joshua M. Korn et al.|Nature Medicine|2015

Cited by 1.4k

Quantitative Proteomics of the Cancer Cell Line Encyclopedia

David P. Nusinow, Steven P. Gygi, John Szpyt et al.|Cell|2020

Cited by 1k

Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss

Huayang Liu, E. Robert McDonald, Lauren K. Brodeur et al.|Nature Medicine|2018

Cited by 369